:.M*(&@05G-=E=0GO)&B2~4T]BH:JZXCX|7M
SYSTEM PROCESSING...
:.M*(&@05G-=E=0GO)&B2~4T]BH:JZXCX|7M
SYSTEM PROCESSING...
Posted: 2025-04-10 05:53:14 UTC
This article contains some claims that remain unverified. While much of the content may be accurate, exercise care when relying on this information.
This article contains some claims that remain unverified. While much of the content may be accurate, exercise care when relying on this information.
Status
Last Updated
2025-04-10 05:58:51 UTC
Verified By
Rollup News
Researchers from Tufts University have engineered a Lyme bacterial protein, CspZ, to produce a robust immune response in mice for vaccine development.
Engineered Lyme bacterial protein CspZ
Engineered Lyme bacterial protein CspZ
Robust immune response in mice
Robust immune response in mice
Potential for Lyme disease vaccine development
Potential for Lyme disease vaccine development
Engineered Lyme bacterial protein CspZ shows promise as a new target for Lyme disease vaccine development.
The engineered protein produced a robust immune response in mice.
Engineered Lyme bacterial protein CspZ shows promise as a new target for Lyme disease vaccine development.
The engineered protein produced a robust immune response in mice.